Purification and identification of lipolysis-stimulating peptides derived from enzymatic hydrolysis of soy protein.

[1]  Wen-Dee Chiang,et al.  Enhancing the lipolysis-stimulating activity of soy protein using limited hydrolysis with Flavourzyme and ultrafiltration. , 2012, Food chemistry.

[2]  Wen-Dee Chiang,et al.  Enhancing the anti-adipogenic activity of soy protein by limited hydrolysis with Flavourzyme and ultrafiltration. , 2010 .

[3]  Maxine J. Roman,et al.  Fatty acid synthase and in vitro adipogenic response of human adipocytes inhibited by α and α' subunits of soybean β-conglycinin hydrolysates. , 2010 .

[4]  Wan-Teng Lin,et al.  The effect of limited hydrolysis with Neutrase and ultrafiltration on the anti-adipogenic activity of soy protein , 2010 .

[5]  M. Berhow,et al.  Protein hydrolysates from beta-conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitro. , 2009, Molecular nutrition & food research.

[6]  Mak-Soon Lee,et al.  Inhibitory effects of green tea catechin on the lipid accumulation in 3T3‐L1 adipocytes , 2009, Phytotherapy research : PTR.

[7]  Wen-Dee Chiang,et al.  Limited enzymatic hydrolysis of soy protein enhances cholesterol absorption inhibition in Caco-2 cells. , 2009 .

[8]  Meriem Semache,et al.  Lipolysis and the integrated physiology of lipid energy metabolism. , 2008, Molecular genetics and metabolism.

[9]  H. Moon,et al.  Inhibitory Effect of (−)‐Epigallocatechin‐3‐Gallate on Lipid Accumulation of 3T3‐L1 Cells , 2007, Obesity.

[10]  Christine Stephan,et al.  The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells. , 2007, Cancer research.

[11]  D. Langin.  Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. , 2006, Pharmacological research.

[12]  J. Parajó,et al.  Antioxidant properties of ultrafiltration-recovered soy protein fractions from industrial effluents and their hydrolysates , 2006 .

[13]  H. Fujita,et al.  Classification and Antihypertensive Activity of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Food Proteins , 2000 .

[14]  T. Aoyama,et al.  Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK) , 2000, Nutrition.

[15]  Y. Chu,et al.  Functional properties of soy protein hydrolysate produced from a continuous membrane reactor system , 1999 .

[16]  Y. Watanabe,et al.  Globin digest, acidic protease hydrolysate, inhibits dietary hypertriglyceridemia and Val-Val-Tyr-Pro, one of its constituents, possesses most superior effect. , 1996, Life sciences.

[17]  Y. Kitagawa,et al.  Identification of soybean protein components that modulate the action of insulin in vitro. , 1990, Agricultural and biological chemistry.

[18]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[19]  T. Tsai,et al.  Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor , 2006 .

[20]  Jianping Wu,et al.  Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides , 2002 .

[21]  D. Silk,et al.  Effect of peptide chain length on absorption of egg protein hydrolysates in the normal human jejunum. , 1987, Gastroenterology.